@article{pmid29925527,
 author = {Donson, A. M.  and Amani, V.  and Warner, E. A.  and Griesinger, A. M.  and Witt, D. A.  and Levy, J. M. M.  and Hoffman, L. M.  and Hankinson, T. C.  and Handler, M. H.  and Vibhakar, R.  and Dorris, K.  and Foreman, N. K. },
 journal = {Mol. Cancer Ther.},
 month = {09},
 note = {[PubMed Central:\hrefhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125158PMC6125158] [DOI:\hrefhttps://dx.doi.org/10.1158/1535-7163.MCT-17-118510.1158/1535-7163.MCT-17-1185] [PubMed:\hrefhttps://www.ncbi.nlm.nih.gov/pubmed/2710954927109549] },
 number = {9},
 pages = {1984--1994},
 title = {Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma},
 volume = {17},
 year = {2018}
}

